-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Bellicum Pharmaceuticals, Inc quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2014 to Q4 2022.
- Bellicum Pharmaceuticals, Inc Deferred Tax Assets, Gross for the quarter ending December 31, 2022 was $135M, a 4.68% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)